Table 2. Baseline characteristics of patients with NGR versus IGR.
| Variables | Total (n = 288) | NGR (n = 138) | IGR (n = 150) | P Value |
|---|---|---|---|---|
| Age (year), mean (SD) | 57.5 (13.2) | 56.2 (14.1) | 58.7 (12.2) | 0.12 |
| Male, n (%) | 192 (66.9) | 98 (71.5) | 94 (62.7) | 0.11 |
| BMI (kg/m2), mean (SD) | 24.6 (4.2) | 24.5 (5.0) | 24.6 (3.4) | 0.50 |
| Medical history, n (%) | ||||
| Hypertension | 188 (65.3) | 90 (65.2) | 98 (65.3) | 0.98 |
| Dyslipidemia | 10 (3.5) | 2 (1.5) | 8 (5.3) | 0.14 |
| Coronary heart disease | 23 (8.0) | 16 (11.6) | 7 (4.7) | 0.03 |
| Atrial fibrillation | 6 (2.1) | 2 (1.5) | 4 (2.7) | 0.76 |
| Stroke | 28 (10.6) | 17 (13.0) | 11 (8.3) | 0.21 |
| Pre-disability | 2 (0.01) | 2 (0.01) | 0 (0.0) | 0.23 |
| On admission status | ||||
| NIHSS score, median (IQR) | 6 (2–12) | 6 (2–11) | 7 (2–13) | 0.09 |
| GCS score, median (IQR) | 15 (13–15) | 15 (13–15) | 15 (12–15) | 0.35 |
| SBP (mmHg), mean (SD) | 156 (24) | 156 (26) | 155 (22) | 0.82 |
| DBP (mmHg), mean (SD) | 92 (15) | 92 (15) | 92 (14) | 0.92 |
| Hematoma location, n (%) | 0.12 | |||
| Lobes | 41 (14.2) | 16 (11.6) | 25 (16.7) | |
| Basal ganglia region | 203 (70.5) | 93 (67.4) | 110 (73.3) | |
| Brain stem | 15 (5.2) | 9 (6.5) | 6 (4.0) | |
| Cerebellum | 17 (5.9) | 11 (8.0) | 6 (4.0) | |
| Intraventricular extension | 7 (2.4) | 6 (4.4) | 1 (0.7) | |
| TG on admission (mmol/L), median (IQR) | 1.4 (1.1–2.0) | 1.3 (0.9–1.9) | 1.5 (1.2–2.0) | 0.05 |
| HbA1c on admission (%),median (IQR) | 5.5 (5.0–6.0) | 5.3 (4.7–5.8) | 5.7 (5.2–6.2) | <0.001 |
| FPG on admission (mmol/L), median (IQR) | 5.4(4.8–6.1) | 5.1(4.6–5.8) | 5.6(5.1–6.4) | <0.001 |
| FPG at 14d (mmol/L), median (IQR) | 4.9 (4.5–5.5) | 4.7 (4.3–5.1) | 5.1 (4.7–5.7) | <0.001 |
| 2-h PG at 14d (mmol/L), median (IQR) | 7.7 (6.7–9.2) | 6.7 (5.8–7.2) | 9.1 (8.4–10.1) | <0.001 |
| Medication in hospital, n (%) | ||||
| Oral hypoglycemic agents | 2 (0.7) | 0 (0.0) | 2 (1.3) | 0.52 |
| Insulin administration | 10 (3.5) | 5 (3.6) | 5 (3.3) | 1.0 |
| Antihypertensive therapy | 193 (67.0) | 95 (68.8) | 98 (65.3) | 0.53 |
| In-hospital pulmonary infection, n (%) | 40(13.9) | 16(11.6) | 24(16.0) | 0.28 |
| In-hospital urinary infection, n (%) | 10 (3.5) | 3 (2.2) | 7 (4.7) | 0.41 |
P values refer to the comparisons between IGR and NGR groups. NGR indicates normal glucose tolerance; IGR, impaired glucose regulation; SD, standard deviation; IQR, interquartile range; BMI, body mass index; NIHSS, National Institute of Health Stroke Scale; GCS, Glasgow Coma Scale; SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglyceride; HbA1c, glycosylated hemoglobin; FPG, fasting plasma glucose; and 2-h PG, 2-hour plasma glucose.